Intercept Pharmaceuticals buy melinda
Start price
12.02.18
/
50%
€49.29
Target price
20.02.18
€60.43
Performance (%)
14.93%
End price
20.02.18
€56.65
Summary
This prediction ended on 20.02.18 with a price of €56.65. The prediction had a final performance of 14.93%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intercept Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 0.869% | 3.389% | 22.351% | 71.506% |
| iShares Nasdaq 100 | -0.852% | -2.157% | 5.543% | 107.710% |
| iShares Nikkei 225® | 0.436% | 1.060% | 13.273% | 46.809% |
| iShares S&P 500 | -0.122% | -0.270% | 3.350% | 65.323% |
Comments by melinda for this prediction
In the thread Intercept Pharmaceuticals diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 14/02 Ergebnisse Veröffentlichung
Intercept kündigt Phase - 3 - Studie zur Evaluierung REVERSE OCA zur Behandlung von NASH - Patienten mit kompensierter Zirrhose
12. April 18
(Vom Mitglied beendet)
Stopped prediction by melinda for Intercept Pharmaceuticals
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€104.05
03.04.19
03.04.19
€112.75
04.11.21
04.11.21
-79.94%
04.01.21
04.01.21
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€103.55
30.11.18
30.11.18
€108.24
22.01.19
22.01.19
-2.77%
22.01.19
22.01.19
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€57.01
08.03.18
08.03.18
€63.14
05.04.18
05.04.18
13.13%
05.04.18
05.04.18
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€51.64
28.09.17
28.09.17
€90.20
03.10.17
03.10.17
15.83%
03.10.17
03.10.17
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€114.84
13.03.17
13.03.17
€121.77
28.07.17
28.07.17
6.13%
28.07.17
28.07.17
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€146.12
07.04.16
07.04.16
€171.38
07.10.16
07.10.16
-5.24%
07.10.16
07.10.16
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€25.00
19.06.13
19.06.13
€27.00
19.12.13
19.12.13
65.99%
19.12.13
19.12.13